Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Petrini

Showing results (191-200 of 254) with videos related to

Pageof 26
Sort By:
Nanotechnology|October 24, 2013
Boron nitride nanotubes and primary human osteoblasts: in vitro compatibility and biological interactions under low frequency ultrasound stimulationSerena Danti, Gianni Ciofani, Stefania Moscato, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2012
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignanciesPaola A Erba, Martina Sollini, Enrico Orciuolo, et al.
British Journal of Haematology|May 16, 2020
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphomaFulvio Massaro, Yana Stepanishyna, Martina Manni, et al.
Leukemia Research|October 27, 2005
Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Infection|January 23, 2018
Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literatureGregorio Di Franco, Enrico Tagliaferri, Erica Pieroni, et al.
Oncotarget|December 13, 2019
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myelomaSimone Pacini, Marina Montali, Francesco Mazziotta, et al.
Leukemia Research|June 28, 2005
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 26, 2009
Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitutionDaniele Focosi, Fabrizio Maggi, Melania Albani, et al.
Blood|January 10, 2009
Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patientsStefanie Sauer, Paola A Erba, Mario Petrini, et al.
Journal of Medical Case Reports|September 28, 2011
Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case reportGiovanni Carulli, Alessandra Marini, Eugenio M Ciancia, et al.
Pageof 26

Showing results (191-200 of 254) with videos related to

Sort By:
Pageof 26
Nanotechnology|October 24, 2013
Boron nitride nanotubes and primary human osteoblasts: in vitro compatibility and biological interactions under low frequency ultrasound stimulationSerena Danti, Gianni Ciofani, Stefania Moscato, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2012
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignanciesPaola A Erba, Martina Sollini, Enrico Orciuolo, et al.
British Journal of Haematology|May 16, 2020
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphomaFulvio Massaro, Yana Stepanishyna, Martina Manni, et al.
Leukemia Research|October 27, 2005
Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Infection|January 23, 2018
Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literatureGregorio Di Franco, Enrico Tagliaferri, Erica Pieroni, et al.
Oncotarget|December 13, 2019
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myelomaSimone Pacini, Marina Montali, Francesco Mazziotta, et al.
Leukemia Research|June 28, 2005
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 26, 2009
Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitutionDaniele Focosi, Fabrizio Maggi, Melania Albani, et al.
Blood|January 10, 2009
Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patientsStefanie Sauer, Paola A Erba, Mario Petrini, et al.
Journal of Medical Case Reports|September 28, 2011
Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case reportGiovanni Carulli, Alessandra Marini, Eugenio M Ciancia, et al.
Pageof 26